» Articles » PMID: 30333606

The Immune Response Against Flaviviruses

Overview
Journal Nat Immunol
Date 2018 Oct 19
PMID 30333606
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Arthropod-borne flaviviruses are important human pathogens that cause a diverse range of clinical conditions, including severe hemorrhagic syndromes, neurological complications and congenital malformations. Consequently, there is an urgent need to develop safe and effective vaccines, a process requiring better understanding of the immunological mechanisms involved during infection. Decades of research suggest a paradoxical role of the immune response against flaviviruses: although the immune response is crucial for the control, clearance and prevention of infection, poor clinical outcomes are commonly associated with virus-specific immunity and immunopathogenesis. This relationship is further complicated by the high homology among viruses and the implication of cross-reactive immune responses in protection and pathogenesis. This Review examines the dual role of the adaptive immune response against flaviviruses, particularly emphasizing the most recent findings regarding cross-reactive T cell and antibody responses, and the effects that these concepts have on vaccine-development endeavors.

Citing Articles

Effect of the CSFV NS5A protein on key proteins in the MAPK and PI3K-mTOR signaling pathways in porcine macrophages.

Wang Y, Zheng X, Yang Y, Zhao X, Li M, Huang J Front Microbiol. 2025; 16:1559840.

PMID: 40078537 PMC: 11897277. DOI: 10.3389/fmicb.2025.1559840.


Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection.

Volz A, Clever S, Tscherne A, Freudenstein A, Jany S, Schwarz J NPJ Vaccines. 2025; 10(1):44.

PMID: 40044709 PMC: 11882785. DOI: 10.1038/s41541-025-01094-0.


Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort.

Wullimann D, Sandberg J, Akber M, Lofling M, Gredmark-Russ S, Michaelsson J PLoS Negl Trop Dis. 2025; 19(2):e0012693.

PMID: 40019865 PMC: 11893121. DOI: 10.1371/journal.pntd.0012693.


Identifying Allosteric Small-Molecule Binding Sites of Inactive NS2B-NS3 Proteases of Pathogenic .

Grabski H, Grabska S, Abagyan R Viruses. 2025; 17(1).

PMID: 39861795 PMC: 11769402. DOI: 10.3390/v17010006.


RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?.

Stegeman S, Kourko O, Amsden H, Pellizzari Delano I, Mamatis J, Roth M J Innate Immun. 2025; 17(1):126-153.

PMID: 39820070 PMC: 11845175. DOI: 10.1159/000543608.